Research · Randomised controlled trial
Antihyperlipidemic effects of spirulina in patients with type 2 diabetes
Mani et al. · 2000 · Journal of Nutritional Science and Vitaminology
Key finding
In patients with type 2 diabetes, 2 g/day spirulina significantly reduced fasting blood glucose, HbA1c, total cholesterol, LDL, VLDL, and triglycerides. HDL increased modestly.
Why this matters for consumers
Demonstrates lipid and glycaemic effects at a low dose (2 g/day) in a population with established metabolic dysfunction. This is the population where spirulina's benefit is most clinically meaningful.
Study limitations
Small sample; no mention of dietary control between groups; baseline comparability not fully reported.
Related studies
Spirulina maxima prevents induction of fatty liver by carbon tetrachloride
Torres-Durán et al. · 2007
Supplementation with spirulina in a standard anti-diabetic regimen
Parikh et al. · 2001
Anti-obesity and anti-inflammatory effects of spirulina in obese adults
Park et al. · 2008
Spirulina supplementation improves lipid profile and oxidative stress in non-alcoholic fatty liver disease
Ismail et al. · 2015
New research, when it matters
Curated science, recipes, and brand intel — once a week, no spam, unsubscribe in one click.